Product Recalls: September 15, 2021 – October 13, 2021
Health Letter, November 2021
Note: Never stop taking a drug that appears on the product recall list without first talking to your doctor or pharmacist. Most recalls are limited to a single manufacturer and may not be related to the version of a particular drug you are taking. If a recall does relate to the version of the drug you are taking, you should not stop taking the drug until you discuss an alternative treatment with your doctor or pharmacist.
CLASS I
Ruzurgi (amifampridine) tablets, 10 mg, 100-count bottles. Manufactured by: Jacobus Pharmaceutical Company, Inc. Lot #: 18038 or 18039, exp. date: 03/2023; Lot #: 18079, exp. date: 05/2023.
CLASS II
Carbamazepine tablets, 200 mg, 100-count unit dose cartons. Manufactured by: Torrent Pharmaceuticals Ltd. Lot #: R01562, exp. date: 10/2022.
Chantix (varenicline) tablets, 0.5 mg/1 mg, 56 tablets. Distributed by Pfizer Labs, Division of Pfizer Inc. Lot #: 00018522, 00018523, 00018739, 00018740, 00020231, 00020232, 00020357, 00020358, 00020716, 00020813, 00021288, 00021289, 00021420, 00021687, 00021688, 00021788, 00021789, 00021790, 00021791, 00021792, 00022819, 00022851, 00023136, 00023137, 00023190, 00023448, DM0275, DM0276, DM0277, DY4470, EC5911, EC5912, ED6814, ET1600, ET1603, ET1607, ET1609 or ET1611, exp. date: August 2021 through January 2023; Lot #: CY6861, DM9007, DM9008, EN5725, EN8362 or EN8467, exp. date: January 2022 through May 2023; Lot #: 00018777, 00019289, 00019593, 00019682, 00019846, 00019977, 00020295, 00020448, 00020458, 00020480, 00021024, 00021073, 00021074, CW1565, CW1566, CW1567, CW1568, CW1569, CW1570, CW1571, CW1572, CW1573, CW1574, CW1575, CW1578, CW1579, CW1581, DF5277, DF5278, DF5279, DF5280, DF5281, DF5282, DR5086, DR5092, DR5093, DR5094, DT3885, DW4148, DW4152, DY7987, EC9841, EC9842, EC9847, EC9848, EE1011, EM1069, EM1070, EN5694, EN5695, EP1717, EP1718, EP1719, EW2012, EW3854, EW3865, EX2102 or EX2103, exp. date: September 2021 through December 2023; Lot #: 00019431, 00019542, 00019543, 00019544, 00020814, 00020815, 00020907, 00020965, 00021421, 00021422, 00021423, 00022136, 00022174, 00022175, 00022176, 00022177, 00022765, 00022766, 00023134, 00023135, 00023747, 00023748, DL3896, DL7779, DR2614, DX4576, DX5870, DX5871, DX5872, DX5873, DX7805, DY6078, DY7060, DY9367, DY9473, DY9475, DY9476, DY9505, EC5910, EC5913, EE9391, EF2346, EM4805, EM4807, EN2005, ET1601, ET1605 or ET1606, exp. date: September 2021 December 2023.
Chlorzoxazone tablets, 375 or 750 mg, 100 tablets. Manufactured by: Glenmark Pharmaceuticals Inc. Lot #: 29200022, exp. date: 03/31/2022; Lot: 29200024, exp. date: 03/31/2022; Lot #: 29200035, exp. date: 06/30/2022; Lot #: 29200023, exp. date: 03/31/2022; Lot #: 29200025, exp. date: 03/31/2022; Lot #: 29200036, exp. date: 06/30/2022; Lot: 29200056, exp. date: 09/30/2022; Lot #: 29200070, exp. date: 11/30/2022.
Entacapone tablets, 200 mg, 30 tablets per unit dose cartons. Distributed by: Major Pharmaceuticals. Lot #: N00187, exp. date: 05/2022; Lot #: N00245, exp. date: 06/2022; Lot #: N00273, exp. date: 07/2022; Lot #: N00355, exp. date: 11/2022.
Lyrica CR (pregabalin) extended-release tablets, 330 mg, 30-count bottles. Distributed by Parke-Davis Division of Pfizer Inc. Lot #: DN5396, EP9726 or EK2417, exp. date: August 2022.
Meclizine HCl tablets, 25 mg, 100-count HDPE bottle. Distributed by: Rising Pharma Holdings, Inc. Manufactured by: Aurex laboratories LLC. Lot #: CB21024, exp. date: 2/2023.
Metoprolol tartrate tablets, 100 mg, 1,000-count bottles. Distributed by: Aurobindo Pharma USA Inc. Lot #: MJ1019025-A, exp. date: 04/2022.
Naproxen sodium tablets, 275 or 550 mg, 100 tablets. Manufactured by: Glenmark Pharmaceuticals Inc. Lot #: 29190087, exp. date: 10/31/2021; Lot #: 29190088, exp. date: 10/31/2021; Lot #: 29190089, exp. date: 10/31/2021; Lot #: 29200077, exp. date: 11/30/2022; Lot #: 29200078, exp. date: 11/30/2022; Lot #: 29190082, exp. date: 09/30/2021; Lot #: 29190083, exp. date: 09/30/2021; Lot #: 29190084, exp. date: 10/31/2021; Lot #: 29190085, exp. date: 10/31/2021; Lot #: 29200001, exp. date: 12/31/2021; Lot #: 29200003, exp. date: 01/31/2022; Lot #: 29200004, exp. date: 01/31/2022; Lot #: 29200005, exp. date: 01/31/2022; Lot #: 29200012, exp. date: 02/28/2022; Lot #: 29200013, exp. date: 02/28/2022; Lot #: 29200010, exp. date: 02/28/2022.
Oxycodone hydrochloride tablets, 10 mg, 100-count bottle. Marketed by: Rhodes Pharmaceuticals L.P. Manufactured by: Purdue Pharma L.P. Lot #: WP5K0Y, exp. date: 02/28/2023.
Zonisamide capsules, 50 or 100 mg, 30 or 100 capsules. Manufactured by: Glenmark Pharmaceuticals Inc. Lot #: 29190043, exp. date: 05/31/2022; Lot #: 29190044, exp. date: 05/31/2022; Lot #: 29190045, exp. date: 05/31/2022; Lot #: 29200014, exp. date: 02/28/2023; Lot #: 29200015, exp. date: 03/31/2023; Lot #: 29200016, exp. date: 03/31/2023; Lot #: 29200030, exp. date: 05/31/2023; Lot #: 29200031, exp. date: 05/31/2023; Lot #: 29200032, exp. date: 05/31/2023; Lot #: 29200033, exp. date: 06/30/2023; Lot #: 29200037, exp. date: 06/30/2023; Lot #: 29200038, exp. date: 06/30/2023; Lot #: 29200039, exp. date: 07/31/2023; Lot #: 29200041, exp. date: 07/31/2023; Lot #: 29200042, exp. date: 07/31/2023; Lot #: 29200048, exp. date: 08/31/2023; Lot #: 29200049, exp. date: 08/31/2023; Lot #: 29200050, exp. date: 08/31/2023; Lot #: 29200072, exp. date: 11/30/2023; Lot #: 29200073, exp. date: 11/30/2023; Lot #: 29200074, exp. date: 11/30/2023; Lot #: 29200075, exp. date: 11/30/2023; Lot #: 29200076, exp. date: 11/30/2023; Lot #: 29200014, exp. date: 02/28/2023; Lot #: 29200015, exp. date: 03/31/2023; Lot #: 29200016, exp. date: 03/31/2023; Lot #: 17JU2118, exp. date: 5/31/23.
For more information about the drug recalls listed above, please visit http://www.accessdata.fda.gov/scripts/ires/index.cfm.
CONSUMER PRODUCTS
For a list of recent recalls of consumer products, please visit the Consumer Product Safety Commission website at http://www.cpsc.gov/en/Recalls/.